Esa denied as not medically necessary by Humana?

Humana's specific coverage criteria for esa are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Denies ESA Claims on Medical-Necessity Grounds

Erythropoiesis-stimulating agents (ESAs) treat anemia by signaling the bone marrow to produce more red blood cells. Humana, like most large insurers, requires documented evidence that the anemia has a cause that ESA therapy is clinically appropriate to address — most commonly chronic kidney disease or chemotherapy-induced anemia — and that the patient's laboratory values and clinical condition meet the thresholds in the insurer's own published coverage policy. When the chart does not clearly document those elements, a medical-necessity denial typically follows.

## Why This Denial Is Appealable

Medical-necessity determinations are judgment calls made by a reviewer who has not examined your patient. If the prescribing clinician has documented a qualifying diagnosis, a hemoglobin or hematocrit trend in the chart, and a reasoned explanation for why ESA therapy is indicated, the factual record supports reversal. Payers must apply their stated criteria consistently, and an appeal forces a second, independent look.

## Federal Appeal Framework

• Internal appeal (ERISA §503 / ACA §2719): You have the right to a full-and-fair internal review. Submit within the deadline stated in the denial letter (commonly 180 days for non-grandfathered plans).
• External review (ACA §2719): After exhausting the internal process, you may request an Independent Review Organization (IRO) review. The IRO decision is binding on the plan. Request this within approximately four months of the final internal denial — confirm the exact window in your denial letter.
• Expedited option: If the patient's condition is urgent, request simultaneous expedited internal and external review.

## Concrete Appeal Steps

1. Request the complete denial letter and the plan's Evidence of Coverage or Summary Plan Description. 2. Obtain Humana's current published medical policy for ESAs (available on the Humana provider portal). 3. Have the prescriber draft a detailed medical-necessity letter. 4. Submit the internal appeal with the documentation package below. 5. If denied again, file for external IRO review.

## Documentation to Gather

• Diagnosis confirmation: Chart notes and lab reports establishing the qualifying diagnosis (e.g., CKD stage, cancer diagnosis with active chemotherapy).
• Hemoglobin/hematocrit trend: Serial lab results showing the trajectory that prompted the prescription. Do not state specific numbers here — attach the actual lab printouts.
• Prior-treatment history: Documentation of any iron supplementation or other anemia management attempted first, with dates and outcomes.
• Clinical severity: Physician notes describing functional impact (fatigue, exercise intolerance, transfusion history).
• Prescriber medical-necessity letter: Should map, criterion by criterion, to the requirements in the FDA-approved prescribing label and to Humana's published policy — without asserting numbers not in the chart.

## Criteria-Mapping Structure

Create a two-column table. In the left column, copy each criterion verbatim from (a) the FDA-approved ESA prescribing label and (b) Humana's current ESA medical policy. In the right column, cite the exact chart entry — date, page, and value — that satisfies it. If a criterion is not met, address it directly rather than leaving a gap the reviewer will notice.